We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$223M
AUM Growth
-$8.35M
Cap. Flow
-$24.5M
Cap. Flow %
-10.95%
Top 10 Hldgs %
20.61%
Holding
136
New
42
Increased
20
Reduced
34
Closed
39

Top Sells

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$4.52M
2
FNSR
Finisar Corp
FNSR
+$4.23M
3
PODD icon
Insulet
PODD
+$3.48M
4
MIDD icon
Middleby
MIDD
+$3.47M
5
VRA icon
Vera Bradley
VRA
+$3.42M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.12%
2 Industrials 19.73%
3 Technology 15.84%
4 Healthcare 15.83%
5 Energy 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAS
76
DELISTED
Basis Energy Services, Inc.
BAS
$1.15M 0.51%
69
-144
-68% -$2.19M
ISEE
77
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.14M 0.51%
+26,835
New +$985K
FTK icon
78
Flotek Industries
FTK
$985M
$1.12M 0.5%
+5,793
New +$1.02M
PVA
79
DELISTED
PENN VIRGINIA CORP
PVA
$1.09M 0.49%
64,325
-110,265
-63% -$1.75M
ZUMZ icon
80
Zumiez
ZUMZ
$207M
$990K 0.44%
+35,900
New +$954K
LDRH
81
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$946K 0.42%
37,806
-72,370
-66% -$1.82M
MCHX icon
82
Marchex
MCHX
$57.6M
$945K 0.42%
78,630
+21,930
+39% +$231K
EVDY
83
DELISTED
Everyday Health, Inc.
EVDY
$916K 0.41%
+49,565
New +$774K
SYNA icon
84
Synaptics
SYNA
$3.74B
$904K 0.4%
+9,975
New +$676K
EXAS
85
DELISTED
Exact Sciences
EXAS
$900K 0.4%
52,835
-11,380
-18% -$157K
ZG icon
86
Zillow
ZG
$7.35B
$768K 0.34%
+16,110
New +$591K
INWK
87
DELISTED
InnerWorkings, Inc.
INWK
$764K 0.34%
+89,940
New +$672K
EXAM
88
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$710K 0.32%
22,391
-70,944
-76% -$2.33M
ZOES
89
DELISTED
Zoe's Kitchen, Inc.
ZOES
$703K 0.31%
+20,440
New +$592K
PRLB icon
90
Protolabs
PRLB
$1.97B
$681K 0.3%
+8,310
New +$563K
MDXG icon
91
MiMedx Group
MDXG
$687M
$584K 0.26%
+82,385
New +$482K
ALNY icon
92
Alnylam Pharmaceuticals
ALNY
$31.9B
$577K 0.26%
+9,140
New +$543K
AVNR
93
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$577K 0.26%
+102,390
New +$472K
SGMO
94
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$546K 0.24%
+35,730
New +$514K
AVDL
95
DELISTED
Avadel Pharmaceuticals
AVDL
$515K 0.23%
+34,345
New +$414K
PCTY icon
96
Paylocity
PCTY
$7.75B
$469K 0.21%
+21,705
New +$428K
SBNY
97
DELISTED
Signature Bank
SBNY
$418K 0.19%
3,310
AEIS icon
98
Advanced Energy
AEIS
$10.3B
-131,350
Closed -$3.22M
AXON
99
Axon Enterprise
AXON
$37.2B
-182,995
Closed -$3.35M
CSGP icon
100
CoStar Group
CSGP
$12.6B
-242,150
Closed -$4.52M

Similar funds

Lisanti Capital Growth's Q2 2014 Portfolio in Review

As of Q2 2014, Lisanti Capital Growth held 136 positions worth $223M, down 3.6% from $232M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $24.5M in Q2 2014, closing 39 positions and reducing 34 holdings. Its most notable exit was CoStar Group, an estimated $4.52M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, Lisanti Capital Growth opened a new position in U.S. SILICA HOLDINGS, INC. worth $5.4M.

  • Lisanti Capital Growth's largest Q2 2014 buy was U.S. SILICA HOLDINGS, INC.: 97,365 shares worth $5.4M.
  • Lisanti Capital Growth added most to Finish Line in Q2 2014, an estimated $1.83M increase.
  • Lisanti Capital Growth's biggest Q2 2014 reduction was EXAMWORKS GROUP INC COM STK (DE), cutting an estimated $2.33M.
  • Lisanti Capital Growth fully exited CoStar Group in Q2 2014, selling an estimated $4.52M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $223M portfolio in Q2 2014.
  • Lisanti Capital Growth opened 42 new positions and closed 39 in Q2 2014.
  • Lisanti Capital Growth's portfolio value fell 3.6% quarter-over-quarter to $223M.

Based on Lisanti Capital Growth's 13F filing for Q2 2014, filed 8 Aug 2014.